ABSTRACT
Striatal projection neurons (SPNs) process motor and cognitive information. Their activity is affected by Parkinson's disease, in which dopamine concentration is decreased and acetylcholine concentration is increased. Acetylcholine activates muscarinic receptors in SPNs. Its main source is the cholinergic interneuron that responds with a briefer latency than SPNs during a cortical command. Therefore, an important question is whether muscarinic G-protein coupled receptors and their signaling cascades are fast enough to intervene during synaptic responses to regulate synaptic integration and firing. One of the most known voltage dependent channels regulated by muscarinic receptors is the KV7/KCNQ channel. It is not known whether these channels regulate the integration of suprathreshold corticostriatal responses. Here, we study the impact of cholinergic muscarinic modulation on the synaptic response of SPNs by regulating KV7 channels. We found that KV7 channels regulate corticostriatal synaptic integration and that this modulation occurs in the dendritic/spines compartment. In contrast, it is negligible in the somatic compartment. This modulation occurs on sub- and suprathreshold responses and lasts during the whole duration of the responses, hundreds of milliseconds, greatly altering SPNs firing properties. This modulation affected the behavior of the striatal microcircuit.
Subject(s)
Action Potentials , GABAergic Neurons/physiology , KCNQ Potassium Channels/physiology , Neostriatum/physiology , Synapses/physiology , Action Potentials/drug effects , Animals , Cerebral Cortex/physiology , Cholinergic Neurons/physiology , Electric Stimulation , Excitatory Postsynaptic Potentials/drug effects , GABAergic Neurons/cytology , GABAergic Neurons/metabolism , Intercellular Signaling Peptides and Proteins , Mice, Transgenic , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Neostriatum/cytology , Neostriatum/metabolism , Peptides/pharmacology , Receptor, Muscarinic M1/agonists , Receptor, Muscarinic M1/antagonists & inhibitors , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolismABSTRACT
The external globus pallidus (GPe) is central for basal ganglia processing. It expresses muscarinic cholinergic receptors and receives cholinergic afferents from the pedunculopontine nuclei (PPN) and other regions. The role of these receptors and afferents is unknown. Muscarinic M1-type receptors are expressed by synapses from striatal projection neurons (SPNs). Because axons from SPNs project to the GPe, one hypothesis is that striatopallidal GABAergic terminals may be modulated by M1 receptors. Alternatively, some M1 receptors may be postsynaptic in some pallidal neurons. Evidence of muscarinic modulation in any of these elements would suggest that cholinergic afferents from the PPN, or other sources, could modulate the function of the GPe. In this study, we show this evidence using striatopallidal slice preparations: after field stimulation in the striatum, the cholinergic muscarinic receptor agonist muscarine significantly reduced the amplitude of inhibitory postsynaptic currents (IPSCs) from synapses that exhibited short-term synaptic facilitation. This inhibition was associated with significant increases in paired-pulse facilitation, and quantal content was proportional to IPSC amplitude. These actions were blocked by atropine, pirenzepine, and mamba toxin-7, suggesting that receptors involved were M1. In addition, we found that some pallidal neurons have functional postsynaptic M1 receptors. Moreover, some evoked IPSCs exhibited short-term depression and a different kind of modulation: they were indirectly modulated by muscarine via the activation of presynaptic cannabinoid CB1 receptors. Thus pallidal synapses presenting distinct forms of short-term plasticity were modulated differently.
Subject(s)
Globus Pallidus/physiology , Inhibitory Postsynaptic Potentials , Receptor, Muscarinic M1/metabolism , Synapses/metabolism , Animals , Atropine/pharmacology , Cholinergic Neurons/drug effects , Cholinergic Neurons/metabolism , Cholinergic Neurons/physiology , Globus Pallidus/cytology , Intercellular Signaling Peptides and Proteins , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Peptides/pharmacology , Pirenzepine/pharmacology , Rats , Rats, Wistar , Receptor, Cannabinoid, CB1/metabolism , Receptor, Muscarinic M1/agonists , Receptor, Muscarinic M1/antagonists & inhibitors , Synapses/drug effects , Synapses/physiologyABSTRACT
The role of calcium and its relevance have been deeply revised with respect to trypanosomatids, as the mechanism by which calcium enters trypanosomes was, until now, not well understood. There is evidence supporting the presence of a nAChR in another member of the trypanosomatidae family, Trypanosoma cruzi, these receptors being one entry path to calcium ions. The aims of this work were to determine if there was a nicotinic acetylcholine receptor (nAChR) in Trypanosoma evansi, and to subsequently perform a partial pharmacological characterization of this receptor. After being loaded with FURA-2AM, individual cells of T. evansi, were exposed to cholinergic compounds, and the cells displayed a dose-dependent response to carbachol. This observation indicated that a cholinergic receptor may be present in T. evansi. Although a dose-dependent response to muscarine could not be demonstrated, nicotine could promote an incremental dose-dependent response. The relative potency of this specific agonist of nAChR is in agreement with previous reports. The estimated affinity values were a Kd1 value of 29.6+/-5.72 nM and a Kd2 value of 315.9+/-26.6 nM, which is similar to the Kd value reported for the alpha4 nicotinic receptor. The Hill coefficients were determined to be an n1 of 1.2+/-0.3 and an n2 of 4.2+/-1.3. Finally, our calculations indicated that there are about 1020 receptors in each T. evansi parasite, which is approximately 15-fold lower than the number reported in Torpedo californica electric cells. These results suggest the presence of a nAChR in T. evansi, which is able to bind nicotinic ligands and induce calcium signals.
Subject(s)
Calcium/metabolism , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Receptors, Nicotinic/metabolism , Trypanosoma/metabolism , Animals , Bungarotoxins/metabolism , Dose-Response Relationship, Drug , Male , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Nicotinic Antagonists/pharmacology , Normal Distribution , Rats , Rats, Sprague-Dawley , Receptors, Nicotinic/drug effects , Trypanosoma/drug effectsABSTRACT
Endothelial cells are directly involved in many functions of the cardiovascular system by regulating blood flow and blood pressure through Ca(2+) dependent exocitosis of vasoactive compounds. Using the Ca(2+) indicator Fluo-3 and the patch-clamp technique, we show that bovine adrenal medulla capillary endothelial cells (B AMCECs) respond to acetylcholine (ACh) with a cytosolic Ca(2+) increase and depolarization of the membrane potential (20.3+/-0.9 mV; n=23). The increase in cytosolic Ca(2+) induced by 10microM ACh was mimicked by the same concentration of nicotine but not by muscarine and was blocked by 100 microM of hexamethonium. On the other hand, the increase in cytosolic Ca(2+) could be depressed by nifedipine (0.01 -100 microM) or withdrawal of extracellular Ca(2+). Taken together, these results give evidence for functional nicotinic receptors (nAChRs) in capillary endothelial cells of the adrenal medulla. It suggests that nAChRs in B AMCECs may be involved in the regulation of the adrenal gland's microcirculation by depolarizing the membrane potential, leading to the opening of voltage-activated Ca(2+) channels, influx of external Ca(2+) and liberation of vasoactive compounds.
Subject(s)
Adrenal Medulla/drug effects , Calcium Channels/drug effects , Cytosol/drug effects , Endothelial Cells/drug effects , Nicotine/pharmacology , Receptors, Nicotinic/drug effects , Acetylcholine/pharmacology , Adrenal Medulla/blood supply , Adrenal Medulla/cytology , Animals , Calcium Channels/metabolism , Capillaries/cytology , Capillaries/drug effects , Cattle , Cytosol/metabolism , Evoked Potentials/drug effects , Hexamethonium/pharmacology , Membrane Potentials/drug effects , Muscarine/pharmacology , Receptors, Nicotinic/metabolismABSTRACT
Endothelial cells are directly involved in many functions of the cardiovascular system by regulating blood flow and blood pressure through Ca2+ dependent exocitosis of vasoactive compounds. Using the Ca2+ indicator Fluo-3 and the patch-clamp technique, we show that bovine adrenal medulla capillary endothelial cells (B AMCECs) respond to acetylcholine (ACh) with a cytosolic Ca2+ increase and depolarization of the membrane potential (20.3±0.9 mV; n=23). The increase in cytosolic Ca2+ induced by 10µM ACh was mimicked by the same concentration of nicotine but not by muscarine and was blocked by 100 µM of hexamethonium. On the other hand, the increase in cytosolic Ca2+ could be depressed by nifedipine (0.01 -100 µM) or withdrawal of extracellular Ca2+. Taken together, these results give evidence for functional nicotinic receptors (nAChRs) in capillary endothelial cells of the adrenal medulla. It suggests that nAChRs in B AMCECs may be involved in the regulation of the adrenal gland's microcirculation by depolarizing the membrane potential, leading to the opening of voltage-activated Ca2+ channels, influx of external Ca2+ and liberation of vasoactive compounds.
Subject(s)
Animals , Cattle , Adrenal Medulla/drug effects , Calcium Channels/drug effects , Cytosol/drug effects , Endothelial Cells/drug effects , Nicotine/pharmacology , Receptors, Nicotinic/drug effects , Acetylcholine/pharmacology , Adrenal Medulla/blood supply , Adrenal Medulla/cytology , Calcium Channels/metabolism , Capillaries/cytology , Capillaries/drug effects , Cytosol/metabolism , Evoked Potentials/drug effects , Hexamethonium/pharmacology , Membrane Potentials/drug effects , Muscarine/pharmacology , Receptors, Nicotinic/metabolismABSTRACT
Coordinated proliferation and differentiation of progenitor cells is the base for production of appropriate numbers of neurons and glia during neuronal development in order to establish normal brain functions. We have used murine embryonal carcinoma P19 cells as an in vitro model for early differentiation to study participation of nicotinic (nAChR) and muscarinic acetylcholine (mAChR) receptors in the proliferation of neural progenitor cells and their differentiation to neurons. We have previously shown that functional nicotinic acetylcholine receptors (nAChRs) already expressed in embryonic cells mediate elevations in cytosolic free calcium concentration ([Ca2+]i) via calcium influx through nAChR channels whereas intracellular stores contribute to nAChR- and mAChR-mediated calcium fluxes in differentiated cells [Resende et al., Cell Calcium 43 (2008) 107-121]. In the present study, we have demonstrated that nicotine provoked inhibition of proliferation in embryonic cells as determined by BrdU labeling. However, in neural progenitor cells nicotine stimulated proliferation which was reversed in the presence of inhibitors of calcium mobilization from intracellular stores, indicating that liberation of intracellular calcium contributed to this proliferation induction. Muscarine induced proliferation stimulation in progenitor cells by activation of Galphaq/11-coupled M1, M3 and M5 receptors and intracellular calcium stores, whereas Galphai/o-protein coupled M2 receptor activity mediated neuronal differentiation.
Subject(s)
Cell Differentiation , Embryonal Carcinoma Stem Cells/pathology , Receptors, Cholinergic/metabolism , Animals , Bromodeoxyuridine/metabolism , Calcium Signaling/drug effects , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cholinergic Agonists/pharmacology , Gene Expression Regulation/drug effects , Intermediate Filament Proteins/genetics , Intermediate Filament Proteins/metabolism , Intracellular Space/drug effects , Intracellular Space/metabolism , Mice , Muscarine/pharmacology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nestin , Neurons/cytology , Neurons/drug effects , Nicotine/pharmacology , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism , Stem Cells/cytology , Stem Cells/drug effects , Type C Phospholipases/metabolismABSTRACT
Besides a reduction of L-type Ca2+-currents (Ca(V)1), muscarine and the peptidic M1-selective agonist, MT-1, reduced currents through Ca(V)2.1 (P/Q) and Ca(V)2.2 (N) Ca2+ channel types. This modulation was strongly blocked by the peptide MT-7, a specific muscarinic M1-type receptor antagonist but not significantly reduced by the peptide MT-3, a specific muscarinic M4-type receptor antagonist. Accordingly, MT-7, but not MT-3, blocked a muscarinic reduction of the afterhyperpolarizing potential (AHP) and decreased the GABAergic inhibitory postsynaptic currents (IPSCs) produced by axon collaterals that interconnect spiny neurons. Both these functions are known to be dependent on P/Q and N types Ca2+ channels. The action on the AHP had an important effect in increasing firing frequency. The action on the IPSCs was shown to be caused presynaptically as it coursed with an increase in the paired-pulse ratio. These results show: first, that muscarinic M1-type receptor activation is the main cholinergic mechanism that modulates Ca2+ entry through voltage-dependent Ca2+ channels in spiny neurons. Second, this muscarinic modulation produces a postsynaptic facilitation of discharge together with a presynaptic inhibition of the GABAergic control mediated by axon collaterals. Together, both effects would tend to recruit more spiny neurons for the same task.
Subject(s)
Acetylcholine/metabolism , Caveolins/physiology , Neostriatum/cytology , Neurons/physiology , Synaptic Transmission/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Calcium Channel Blockers/pharmacology , Caveolin 2 , Caveolins/classification , Caveolins/drug effects , Cells, Cultured , Drug Interactions , Electric Stimulation/methods , In Vitro Techniques , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Muscarine/pharmacology , Muscarinic Agonists/classification , Muscarinic Agonists/pharmacology , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/drug effects , Patch-Clamp Techniques/methods , Rats , Rats, Wistar , Receptors, Muscarinic/classification , Receptors, Muscarinic/drug effects , Synaptic Transmission/drug effectsABSTRACT
Penile reflexes (PRs) were monitored in chronic spinal cord-transected rats by identifying them visually, and at the same time they were recorded as the electromyographic activity of bulbospongiosus muscles. Intraperitoneal injection of the agonist muscarine (10 microg) produced a facilitation of PRs. A decrease in the latency, an increase in the number of clusters and often an increase in the duration of cups were found after muscarine. In addition, 66% (six out of nine) of the animals ejaculated after muscarine. These results suggest that cholinergic receptor stimulation may be involved in erectile and ejaculatory mechanisms mediated by the spinal cord.
Subject(s)
Ejaculation/drug effects , Erectile Dysfunction/drug therapy , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Penile Erection/drug effects , Spinal Cord Injuries/complications , Animals , Ejaculation/physiology , Electromyography , Erectile Dysfunction/etiology , Erectile Dysfunction/physiopathology , Male , Penile Erection/physiology , Rats , Rats, Wistar , Receptors, Muscarinic/physiology , Reflex/drug effects , Spinal Cord Injuries/physiopathologyABSTRACT
The effects of muscarinic receptor stimulation were tested on the urethro genital reflex (UGR) in anesthetized and spinal cord-transected rats. Drugs were applied directly to the spinal cord. The electromyographic activity (EMG) of the bulbospongiosus (BS) muscle was used for recording UGR. In six animals BS as well as soleus, posterior biceps or peroneus tertius muscle EMG was recorded simultaneously. Muscarine (5, 10, 20, 50 and 100 microg) was applied in 22 animals after cutting L6-S1 dorsal roots. Some observations were made on another six animals, to which an extensive bilateral dorsal rhizotomy (L3-S2) was performed. Rhythmic bursts of similar frequency and size to those seen during UGR were found in BS muscle a few minutes after muscarine application. No rhythmic bursting was found on the hindlimb muscles, but exclusively on BS muscles. The effects of homatropine (25, 50, 100 and 200 microg), an acetylcholine muscarinic receptor antagonist, were tested in 21 rats after UGR was elicited three times at low stimulation intensity (7 mm Hg). Homatropine produced two effects: (i) A significant increase in the latency of UGR. (ii) A facilitation of UGR inhibition. In view of these results it can be speculated that muscarinic receptor stimulation is involved in the elicitation of UGR.
Subject(s)
Genitalia, Male/physiology , Receptors, Muscarinic/physiology , Spinal Cord/surgery , Animals , Dose-Response Relationship, Drug , Genitalia, Male/drug effects , Genitalia, Male/innervation , Male , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Parasympatholytics/pharmacology , Penile Erection/drug effects , Rats , Rats, Wistar , Receptors, Muscarinic/drug effects , Reflex/drug effects , Rhizotomy , Tropanes/pharmacologyABSTRACT
Behavioral experiments were conducted to examine the role of the cholinergic receptor-agonist muscarine or its antagonist homatropine on the mating behavior of sexually experienced male rats. Male copulatory behavior was recorded after intrathecally administered saline, muscarine (7.5 microg), or homatropine (25 microg). Changes in copulatory behavior were assessed by the following parameters: intromission latency, intromission frequency, intercopulatory interval, ejaculation latency, and postejaculatory interval. Intromission frequency, intercopulatory interval, and ejaculation latency were decreased significantly by muscarine. Intrathecal homatropine decreased the number of copulating animals (five out of 13). In the five animals that were able to ejaculate after homatropine, intromission latency, intercopulatory interval, and ejaculation latency increased significantly. The effects of both drugs on locomotion were also tested. Muscarine induced no significant changes in locomotion compared with saline. A significant increase in locomotion was found after homatropine treatment. These results suggest that acetylcholine, acting at spinal-cord muscarinic receptors, may be involved in ejaculation.
Subject(s)
Copulation/drug effects , Motor Activity/drug effects , Muscarine/pharmacology , Animals , Copulation/physiology , Ejaculation/drug effects , Ejaculation/physiology , Injections, Spinal , Male , Motor Activity/physiology , Muscarine/administration & dosage , Parasympatholytics/administration & dosage , Parasympatholytics/pharmacology , Rats , Rats, Wistar , Reaction Time , Spinal Cord/drug effects , Spinal Cord/physiology , Tropanes/administration & dosage , Tropanes/pharmacologyABSTRACT
It is demonstrated that acetylcholine released from cholinergic interneurons modulates the excitability of neostriatal projection neurons. Physostigmine and neostigmine increase input resistance (RN) and enhance evoked discharge of spiny projection neurons in a manner similar to muscarine. Muscarinic RN increase occurs in the whole subthreshold voltage range (-100 to -45 mV), remains in the presence of TTX and Cd2+, and can be blocked by the relatively selective M1,4 muscarinic receptor antagonist pirenzepine but not by M2 or M3 selective antagonists. Cs+ occludes muscarinic effects at potentials more negative than -80 mV. A Na+ reduction in the bath occludes muscarinic effects at potentials more positive than -70 mV. Thus, muscarinic effects involve different ionic conductances: inward rectifying and cationic. The relatively selective M2 receptor antagonist AF-DX 116 does not block muscarinic effects on the projection neuron but, surprisingly, has the ability to mimic agonistic actions increasing RN and firing. Both effects are blocked by pirenzepine. HPLC measurements of acetylcholine demonstrate that AF-DX 116 but not pirenzepine greatly increases endogenous acetylcholine release in brain slices. Therefore, the effects of the M2 antagonist on the projection neurons were attributable to autoreceptor block on cholinergic interneurons. These experiments show distinct opposite functions of muscarinic M1- and M2-type receptors in neostriatal output, i.e., the firing of projection neurons. The results suggest that the use of more selective antimuscarinics may be more profitable for the treatment of motor deficits.
Subject(s)
Acetylcholine/physiology , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Neostriatum/physiology , Neurons/physiology , Receptors, Muscarinic/physiology , Animals , Cadmium Chloride/pharmacology , Cesium/pharmacology , Chlorides/pharmacology , Electric Stimulation , In Vitro Techniques , Membrane Potentials/drug effects , Muscarine/pharmacology , Neurons/drug effects , Physostigmine/pharmacology , Pirenzepine/analogs & derivatives , Pirenzepine/pharmacology , Rats , Receptor, Muscarinic M1 , Receptor, Muscarinic M2 , Receptor, Muscarinic M3 , Receptor, Muscarinic M4 , Tetrodotoxin/pharmacologyABSTRACT
We studied the influence of muscarinic and nicotinic stimulation on both phosphoinositide metabolism and intracellular calcium levels in rat skeletal muscle primary cultures. Both nicotine and muscarine induced an increase in cytosolic calcium measured by fluo 3 fluorescence in confocal microscopy. The mass of inositol (1,4,5)trisphosphate measured by radioreceptor assay rose 2- to 3.5-fold upon carbachol, nicotine, or muscarine stimulation. The muscarine effect was mimicked by oxotremorine-M; pirenzepine prevented the muscarine-induced inositol (1,4,5)trisphosphate increase, whereas 4-diphenylacetoxy-N-methyl piperidine methiodide was ineffective. A relatively small (40 fmol/mg protein) high-affinity 3-quinuclidinylbenzilate binding to rat myotube microsomes was consistent with the muscarinic effect found. On the other hand, the effect of nicotine on the mass of inositol (1,4,5)trisphosphate was totally suppressed in sodium-free medium. Expression of Ml muscarinic receptors coupled to phospholipase C and to internal calcium stores in cultured skeletal muscle is proposed; nicotinic receptors could be acting via ion fluxes and membrane depolarization.
Subject(s)
Muscle, Skeletal/metabolism , Receptors, Muscarinic/metabolism , Animals , Animals, Newborn , Calcium/metabolism , Carbachol/pharmacology , Cells, Cultured , Inositol 1,4,5-Trisphosphate/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Muscle, Skeletal/drug effects , Muscle, Skeletal/ultrastructure , Nicotine/pharmacology , Phosphatidylinositols/metabolism , Quinuclidinyl Benzilate/metabolism , Radioligand Assay , RatsABSTRACT
3,4-dihydroxyphenylacetic acid (DOPAC) was measured by differential pulse voltammetry in the neostriatum of anesthetized rats. DL-Muscarine (2.9 nmol) applied into the substantia nigra pars compacta, increased DOPAC concentration in the ipsilateral neostriatum. This effect was blocked by pirenzepine (2.8 nmol), and potentiated by AF-DX 116 (2.8 nmol). These results indicate the existence of two types of muscarinic receptors on dopaminergic neurons, whose activation produces opposing effects on dopamine metabolism in neostriatum.